IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
| Autor: | Petrova, Lucie, Vrbacky, Filip, Lanska, Miriam, Zavrelova, Alzbeta, Zak, Pavel, Hrochova, Katerina |
|---|---|
| Zdroj: | In Clinical Biochemistry November 2018 61:34-39 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect